Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents.
Obesity in adolescents is associated with metabolic risk factors for type 2 diabetes, particularly insulin resistance and excessive accumulation of intrahepatic triglyceride (IHTG). The purpose of this study was to evaluate the effect of moderate weight loss on IHTG content and insulin sensitivity in obese adolescents who had normal oral glucose tolerance. Insulin sensitivity, assessed by using the hyperinsulinemic-euglycemic clamp technique in conjunction with stable isotopically labeled tracer infusion, and IHTG content, assessed by using magnetic resonance spectroscopy, were evaluated in eight obese adolescents (BMI >or=95th percentile for age and sex; age 15.3 +/- 0.6 years) before and after moderate diet-induced weight loss (8.2 +/- 2.0% of initial body weight). Weight loss caused a 61.6 +/- 8.5% decrease in IHTG content (P = 0.01), and improved both hepatic (56 +/- 18% increase in hepatic insulin sensitivity index, P = 0.01) and skeletal muscle (97 +/- 45% increase in insulin-mediated glucose disposal, P = 0.01) insulin sensitivity. Moderate diet-induced weight loss decreases IHTG content and improves insulin sensitivity in the liver and skeletal muscle in obese adolescents who have normal glucose tolerance. These results support the benefits of weight loss therapy in obese adolescents who do not have evidence of obesity-related metabolic complications during a standard medical evaluation.
Vitola
Bernadette E
BE
Department of Medicine, Division of Geriatrics and Nutritional Science and Center for Human Nutrition, Washington University, School of Medicine, St Louis, Missouri, USA.
Deivanayagam
Sheela
S
Stein
Richard I
RI
Mohammed
Balsamanirina S
BS
Magkos
Faidon
F
Kirk
Erik P
EP
Klein
Samuel
S
D000293:Adolescent; D000294:Adolescent Behavior; D001521:Behavior Therapy; D001786:Blood Glucose / Q000378:metabolism; D002149:Energy Intake; D015444:Exercise; D005260:Female; D015309:Glucose Clamp Technique; D005951:Glucose Tolerance Test; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D007700:Kinetics; D008099:Liver / Q000378:metabolism* / Q000503:physiopathology; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism* / Q000503:physiopathology; D009765:Obesity / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D040242:Risk Reduction Behavior; D016896:Treatment Outcome; D014280:Triglycerides / Q000378:metabolism; D015431:Weight Loss
D001786:Blood Glucose; D007328:Insulin; D014280:Triglycerides